Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP

Neutralizing injurious stimuli, proinflammatory mediator catabolism, and polymorphonuclear leukocyte (PMN) clearance are determinants of inflammatory resolution. To this, we recently added innate-type lymphocyte repopulation as being central for restoring postinflammation tissue homeostasis with a role in controlling innate immune–mediated responses to secondary infection. However, although macrophages dominate resolution, their phenotype and role in restoring tissue physiology once inflammation abates are unknown. Therefore, we isolated macrophages from the resolving phase of acute inflammation and found that compared with classically activated proinflammatory M1 cells, resolution-phase macrophages (rMs) possess weaker bactericidal properties and express an alternatively activated phenotype but with elevated markers of M1 cells including inducible cyclooxygenase (COX 2) and nitric oxide synthase (iNOS). This phenotype is controlled by cAMP, which, when inhibited, transforms rM to M1 cells. Conversely, elevating cAMP in M1 cells transforms them to rMs, with implications for cAMP in the resolution of systemic inflammation. It transpires that although rMs are dispensable for clearing PMNs during self-limiting inflammation, they are essential for signaling postresolution lymphocyte repopulation via COX 2 lipids. Thus, rM macrophages are neither classically nor alternatively activated but a hybrid of both, with a role in mediating postresolution innate-lymphocyte repopulation and restoring tissue homeostasis.

[1]  M. Yaqoob,et al.  Novel biphasic role for lymphocytes revealed during resolving inflammation , 2008, Blood.

[2]  Y. Wang,et al.  Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. , 2007, Kidney international.

[3]  S. Youssef,et al.  Type II monocytes modulate T cell–mediated central nervous system autoimmune disease , 2007, Nature Medicine.

[4]  R. Geffers,et al.  Transcriptome Analysis of Murine Macrophages in Response to Infection with Streptococcus pyogenes Reveals an Unusual Activation Program , 2007, Infection and Immunity.

[5]  Primrose P E Freestone,et al.  Specificity of catecholamine-induced growth in Escherichia coli O157:H7, Salmonella enterica and Yersinia enterocolitica. , 2007, FEMS microbiology letters.

[6]  Philip Smith,et al.  Infection with a Helminth Parasite Prevents Experimental Colitis via a Macrophage-Mediated Mechanism1 , 2007, The Journal of Immunology.

[7]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[8]  J. Wallace,et al.  Resolution of in flammation: state of the art, definitions and terms , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  C. Lang,et al.  CYTOKINE-TRIGGERED DECREASES IN LEVELS OF PHOSPHORYLATED EUKARYOTIC INITIATION FACTOR 4G IN SKELETAL MUSCLE DURING SEPSIS , 2006, Shock.

[10]  Judit Ovádi,et al.  Triosephosphate isomerase deficiency: Facts and doubts , 2006, IUBMB life.

[11]  Theo Wallimann,et al.  Mitochondrial creatine kinase in human health and disease. , 2006, Biochimica et biophysica acta.

[12]  E. Mazzon,et al.  Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan. , 2006, Shock.

[13]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[14]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[15]  S. Forbes,et al.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.

[16]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[17]  R. Forster,et al.  Anti‐Oxidative Response of Carbonic Anhydrase III in Skeletal Muscle , 2004, IUBMB life.

[18]  Adriano G. Rossi,et al.  Inflammatory Resolution: new opportunities for drug discovery , 2004, Nature Reviews Drug Discovery.

[19]  Matthijs Kramer,et al.  Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  O. El-Kabbani,et al.  Sorbitol dehydrogenase: structure, function and ligand design. , 2004, Current medicinal chemistry.

[21]  D. Mosser,et al.  The many faces of macrophage activation , 2003, Journal of leukocyte biology.

[22]  P. Freestone,et al.  Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes , 2003, The Lancet.

[23]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[24]  G. Laurent,et al.  Adhesion Molecule–dependent Mechanisms Regulate the Rate of Macrophage Clearance During the Resolution of Peritoneal Inflammation , 2002, The Journal of experimental medicine.

[25]  E. Mazzon,et al.  Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat* , 2002, Critical care medicine.

[26]  T. Lawrence,et al.  Anti-inflammatory lipid mediators and insights into the resolution of inflammation , 2002, Nature Reviews Immunology.

[27]  M. Delgado,et al.  Effect of adrenaline and glucocorticoids on monocyte cAMP-specific phosphodiesterase (PDE4) in a monocytic cell line , 2002, Archives of Dermatological Research.

[28]  A. Ohta,et al.  Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage , 2001, Nature.

[29]  D. Harn,et al.  The Schistosome Oligosaccharide Lacto-N-neotetraose Expands Gr1+ Cells That Secrete Anti-inflammatory Cytokines and Inhibit Proliferation of Naive CD4+ Cells: A Potential Mechanism for Immune Polarization in Helminth Infections , 2001, The Journal of Immunology.

[30]  O. Atochina,et al.  A Schistosome-Expressed Immunomodulatory Glycoconjugate Expands Peritoneal Gr1+ Macrophages That Suppress Naive CD4+ T Cell Proliferation Via an IFN-γ and Nitric Oxide-Dependent Mechanism , 2001, The Journal of Immunology.

[31]  V. Fadok,et al.  Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. , 2001, The Journal of clinical investigation.

[32]  R. Wait,et al.  A modified silver staining protocol for visualization of proteins compatible with matrix‐assisted laser desorption/ionization and electrospray ionization‐ mass spectrometry , 2000, Electrophoresis.

[33]  Hans-Dieter Volk,et al.  Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells , 2000, Journal of Neuroimmunology.

[34]  D. Gilroy,et al.  Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.

[35]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[36]  L. Wahl,et al.  Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. , 1998, Journal of immunology.

[37]  F. Lee.  Cells Tissues and Disease , 1997 .

[38]  C. Haslett,et al.  In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. , 1996, Journal of immunology.

[39]  S. Fleming,et al.  Macrophages have cell surface IL-10 that regulates macrophage bactericidal activity. , 1996, Journal of immunology.

[40]  G. Majno,et al.  Cells, tissues, and disease : principles of general pathology , 1996 .

[41]  N. Day,et al.  Immunosuppressive retroviral peptides: cAMP and cytokine patterns. , 1995, Immunology today.

[42]  E. Unanue,et al.  Immune complexes inhibit antimicrobial responses through interleukin-10 production. Effects in severe combined immunodeficient mice during Listeria infection. , 1995, The Journal of clinical investigation.

[43]  C. Baldwin,et al.  Interleukin-10 downregulates protective immunity to Brucella abortus , 1995, Infection and immunity.

[44]  N. Van Rooijen,et al.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.

[45]  A. Sher,et al.  Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Abramson,et al.  Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. , 1992, Journal of immunology.

[47]  S. Reed,et al.  Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection , 1992, The Journal of experimental medicine.

[48]  Y. Hei,et al.  Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs. , 1991, Molecular pharmacology.

[49]  I. A. Rose,et al.  Proton diffusion in the active site of triosephosphate isomerase. , 1990, Biochemistry.

[50]  B. Jastorff,et al.  [15] cAMP analog antagonists of cAMP action , 1988 .

[51]  B. Jastorff,et al.  cAMP analog antagonists of cAMP action. , 1988, Methods in enzymology.

[52]  J. Miller,et al.  Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymic activity. , 1974, Life sciences.

[53]  W. Spector.  The macrophage in inflammation. , 1970, Series haematologica.